For the Inventor, By the Inventor

Enter assignee name

Albuquerque, NM, United States of America

Respira Therapeutics, Inc.

USPTO Granted Patents = 14

EPO Patents = 3

Trademarks = 2

Forward Citations = 41

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Martin J Donovan (14 out of 24 patents)

Hugh Smyth (13 out of 13 patents)

Robert Curtis (11 out of 14 patents)

4. Zhen Xu (10 out of 29 patents)

5. Revati Shreeniwas (7 out of 7 patents)

6. Dan Deaton (6 out of 7 patents)

7. James Hannon (6 out of 6 patents)

8. Aileen Gibbons (5 out of 5 patents)

9. Alain Romero (4 out of 4 patents)

10. Adaani Frost (4 out of 4 patents)

11. Jeffry G Weers (4 out of 60 patents)

12. Pravin L Soni (3 out of 36 patents)

13. Stephen Lermer (3 out of 3 patents)

14. Jacques Pappo (2 out of 2 patents)

15. Shirley Lyons (1 patent)

14 patents: Sort by Forward Citations

1. 12364701 - PDE5 inhibitor powder formulations and methods relating thereto (2025-07-22),

2. 12263174 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2025-04-01),

3. 11911390 - PDE5 inhibitor powder formulations and methods relating thereto (2024-02-27),

4. 11806314 - PDE5 inhibitor powder formulations and methods relating thereto (2023-11-07),

5. 11491161 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2022-11-08),

6. 11491160 - Methods and compositions for treatment of pulmonary hypertension and other lung disorders (2022-11-08),

7. 11471623 - Powder dispersion methods and devices (2022-10-18),

8. 10912778 - Methods for treatment of pulmonary hypertension (2021-02-09),

9. 10682476 - Powder inhaler, system and methods (2020-06-16),

10. 10525216 - Powder dispersion methods and devices (2020-01-07),

11. 10463815 - Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents (2019-11-05),

12. 10441733 - Powder dispersion devices and methods (2019-10-15),

13. 8651104 - Bead-containing dry powder inhaler (2014-02-18),

14. 8561609 - Dry powder inhaler (2013-10-22),

Respira Therapeutics, Inc. is a leading biopharmaceutical company focused on developing innovative treatments for respiratory diseases. With a strong emphasis on research and development, we are committed to improving the lives of patients by delivering cutting-edge therapies that address unmet medical needs. Our team of experienced scientists and medical professionals are dedicated to advancing the field of respiratory medicine through the discovery of novel drug candidates and targeted delivery technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#40 in Albuquerque, NM

#54 in New Mexico

#21,638 in US

#40,935 in the World

Albuquerque, NM, United States of America

Respira Therapeutics, Inc.

Forward Citations = 41

14 inventors:

Martin J Donovan (14 out of 24 patents)

Hugh Smyth (13 out of 13 patents)

Robert Curtis (11 out of 14 patents)

4. Zhen Xu (10 out of 29 patents)

5. Revati Shreeniwas (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…